156 related articles for article (PubMed ID: 6831469)
21. Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2).
McCormick DL; Becci PJ; Moon RC
Carcinogenesis; 1982; 3(12):1473-6. PubMed ID: 6217919
[TBL] [Abstract][Full Text] [Related]
22. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat.
Moon RC; Thompson HJ; Becci PJ; Grubbs CJ; Gander RJ; Newton DL; Smith JM; Phillips SL; Henderson WR; Mullen LT; Brown CC; Sporn MB
Cancer Res; 1979 Apr; 39(4):1339-46. PubMed ID: 421218
[TBL] [Abstract][Full Text] [Related]
23. Retinoid prevents mammary gland transformation by carcinogenic hydrocarbon in whole-organ culture.
Dickens MS; Custer RP; Sorof S
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5891-5. PubMed ID: 118457
[TBL] [Abstract][Full Text] [Related]
24. Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats.
Armuth V; Berenblum I
Cancer Res; 1974 Oct; 34(10):2704-7. PubMed ID: 4415335
[No Abstract] [Full Text] [Related]
25. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
26. Inhibition by retinoid and ovariectomy of additional primary malignancies in rats following surgical removal of the first mammary cancer.
McCormick DL; Sowell ZL; Thompson CA; Moon RC
Cancer; 1983 Feb; 51(4):594-9. PubMed ID: 6821836
[TBL] [Abstract][Full Text] [Related]
27. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of carcinogenesis by retinoids.
Nettesheim P
Can Med Assoc J; 1980 Apr; 122(7):757-65. PubMed ID: 6988069
[TBL] [Abstract][Full Text] [Related]
29. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid.
Udeani GO; Gerhauser C; Thomas CF; Moon RC; Kosmeder JW; Kinghorn AD; Moriarty RM; Pezzuto JM
Cancer Res; 1997 Aug; 57(16):3424-8. PubMed ID: 9270008
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of neoplasia by minor dietary constituents.
Wattenberg LW
Cancer Res; 1983 May; 43(5 Suppl):2448s-2453s. PubMed ID: 6403236
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate.
McCormick DL; Burns FJ; Albert RE
Cancer Res; 1980 Apr; 40(4):1140-3. PubMed ID: 6766805
[No Abstract] [Full Text] [Related]
33. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
Joseph IB; Vukanovic J; Isaacs JT
Cancer Res; 1996 Aug; 56(15):3404-8. PubMed ID: 8758902
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
35. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat.
Ip C; Singh M; Thompson HJ; Scimeca JA
Cancer Res; 1994 Mar; 54(5):1212-5. PubMed ID: 8118808
[TBL] [Abstract][Full Text] [Related]
36. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
37. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of species, strain, and dose effects in arylamine carcinogenesis.
Weisburger JH; Fiala ES
Natl Cancer Inst Monogr; 1981 Dec; (58):41-8. PubMed ID: 7200572
[No Abstract] [Full Text] [Related]
40. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
